Market Tracker

10/24 6:05pm ET

Alkermes Plc (NASDAQ:ALKS)

45.91
Data as of Oct 24
 +0.63 / +1.39%
Today’s Change
34.28
Today|||52-Week Range
54.25
+12.91%
Year-to-Date

Today’s Trading

Previous close45.28
Today’s open45.57
Day’s range45.27 - 46.39
Volume760,917
Average volume (3 months)875,049
Market cap$6.7B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.91%
Earnings growth (next 5 years)+20.24%
Revenue growth (last year)+47.59%
P/E ratio382.6
Price/Sales5.42
Price/Book6.45

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+8.85+7.00%
TAROTaro Pharmaceutical ...+3.74+2.56%
UTHRUnited Therapeutics ...+3.57+2.78%
PBYIPuma Biotechnology I...-1.44-0.59%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)$0.03
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts